All content of this Internet site is owned or controlled by Janssen Therapeutics, Division of Janssen Products, LP, and is protected by worldwide copyright laws. You may download content only for your personal use for non-commercial purposes but no modification or further reproduction of the content is permitted. The content may otherwise not be copied or used in any way.
The owners of this site will use reasonable efforts to include up-to-date and accurate information in this Internet site, but make no representations, warranties, or assurances as to the accuracy, currency, or completeness of the information provided. The owners of this site shall not be liable for any damages or injury resulting from your access to, or inability to access, this Internet site, or from your reliance on any information provided at this Internet site. This site is for customers, patients and healthcare professionals in the United States.
This Internet site may provide links or references to other sites but the owners of this site have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.
The trademarks, service marks, trade names, trade dress and products in this Internet site are protected in the United States of America and internationally. No use of any of these may be made without the prior, written authorization of the owners of this site, except to identify the products or services of the company.
The sender of any communications to this Internet site or otherwise to the owners of this site shall be responsible for the content and information contained therein, including its truthfulness and accuracy.
IMPORTANT SAFETY INFORMATION
What is the most important information I should know about PREZISTA®?
- PREZISTA® can interact with other medicines and cause serious side effects. See “Who should not take PREZISTA®?”
- PREZISTA® may cause liver problems. Some people taking PREZISTA®, together with NORVIR® (ritonavir), have developed liver problems which may be life-threatening. Your healthcare provider should do blood tests before and during your combination treatment with PREZISTA®. If you have chronic hepatitis B or C infection, your healthcare provider should check your blood tests more often because you have an increased chance of developing liver problems
- Tell your healthcare provider if you have any of these signs and symptoms of liver problems: dark (tea-colored) urine, yellowing of your skin or whites of your eyes, pale-colored stools (bowel movements), nausea, vomiting, pain or tenderness on your right side below your ribs, loss of appetite, or tiredness.
- PREZISTA® may cause severe or life-threatening skin reactions or rash. Sometimes these skin reactions and skin rashes can become severe and require treatment in a hospital. You should call your healthcare provider immediately if you develop a rash. Stop taking PREZISTA® and ritonavir combination treatment and call your healthcare provider immediately if you develop any skin changes with these symptoms: fever, tiredness, muscle or joint pain, blisters or skin lesions, mouth sores or ulcers, red or inflamed eyes, like “pink eye.” Rash occurred more often in people taking PREZISTA® and raltegravir together than with either drug separately, but was generally mild.
What is PREZISTA®?
PREZISTA® (darunavir) is a prescription HIV-1 (Human Immunodeficiency Virus type-1) medicine used with NORVIR®(ritonavir) and other antiretroviral medicines to treat HIV-1 infection in adults. HIV is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).
PREZISTA® should not be used in children under 3 years of age.
When used with other antiretroviral medicines to treat HIV-1 infection, PREZISTA® may help:
- reduce the amount of HIV-1 in your blood. This is called “viral load.”
- increase the number of CD4+ (T) cells in your blood that help fight off other infections.
PREZISTA® is always taken with and at the same time as NORVIR® (ritonavir) in combination with other HIV-1 medicines for the treatment of HIV-1 infection in adults. PREZISTA® should also be taken with food.
PREZISTA® does not cure HIV-1 infection or AIDS . You must keep taking HIV-1 medicines to control HIV-1 infection and decrease HIV-related illnesses.
Ask your healthcare provider if you have any questions on how to prevent passing HIV to other people.
Please read the Important Safety Information and talk to your healthcare provider to learn if PREZISTA® is right for you.
Who should not take PREZISTA®?
Do not take PREZISTA® if you are taking the following medicines:alfuzosin (Uroxatral® ), ergotcontaining medicines: dihydroergotamine (D.H.E. 45® , Embolex® , Migranal® ), ergotamine tartrate (Cafergot® , Ergomar® , Ergostat® , Medihaler ergotamine ® , Migergot® , Wigraine® , Wigrettes® ), methylergonovine (Ergotrate® , Methergine® ), cisapride (Propulside® , Propulsid® Quicksolv), colchicine (Colcrys® , Mitigare® ), if you have liver or kidney problems, dronedarone (Multaq® ), lurasidone (Latuda®), pimozide (Orap® ), midazolam (Versed® ), when taken by mouth, ranolazine (Ranexa®), St. John's Wort (Hypericum perforatum) or a product that contains St. John's Wort, lovastatin or a product that contains lovastatin (Altoprev® , Advicor® , Mevacor® ), simvastatin or a product that contains simvastatin (Simcor® , Vytorin® , Zocor® ), rifampin or a product that contains rifampin (Rifadin® , Rifater® , Rifamate® , Rimactane® ), sildenafil (Revatio®), when used for the treatment of pulmonary arterial hypertension (PAH), or triazolam (Halcion® ).
Serious problems can happen if you or your child takes any of these medicines with PREZISTA®.
What should I tell my healthcare provider before taking PREZISTA®?
Before taking PREZISTA®, tell your healthcare provider if you:
- have liver problems (including hepatitis B or C), allergy to sulfa medicines, high blood sugar (diabetes), hemophilia, or any other medical conditions.
- are pregnant or planning to become pregnant. Tell your healthcare provider if you become pregnant while taking PREZISTA®.
- are breastfeeding or plan to breastfeed. Do not breastfeed if you take PREZISTA®. You should not breastfeed if you have HIV because of the risk of passing HIV to your baby. It is not known if PREZISTA® can pass into your breast milk. Talk to your healthcare provider about the best way to feed your baby.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicine, vitamins, and herbal supplements. Some medicines interact with PREZISTA®. Keep a list of your medicines to show your healthcare provider and pharmacist. Do not start taking a new medicine without telling your healthcare provider.
What are the possible side effects of PREZISTA®?
PREZISTA® may cause serious side effects, including:
- High blood sugar, diabetes or worsening of diabetes, and increased bleeding in people with hemophilia have been reported in patients taking protease inhibitor medicines, including PREZISTA®
- Changes in body fat can happen to people who take HIV medicines. The exact cause and long-term health effects of these conditions are not known.
- Changes in your immune system can happen when you start taking HIV medicines. Your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time.
The most common side effects of PREZISTA® include diarrhea, nausea, rash, headache, stomach pain, and vomiting.
This is not a complete list of all possible side effects. If you experience these or other side effects, talk to your healthcare provider. Do not change your dose or stop taking PREZISTA® without talking to your healthcare provider.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You may also report side effects to Janssen Products, LP at 1-800-JANSSEN (1-800-526-7736).
Please refer to the NORVIR® (ritonavir) Product Information Leaflet for additional information on precautionary measures.
Please see full Product Information for more details.